FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1511204218> ?p ?o ?g. }

• W1511204218 endingPage "1127" @default.
• W1511204218 startingPage "1119" @default.
• W1511204218 abstract "Background and purpose: AE9C90CB (N- [(1R, 5S, 6R)-3-azabicyclo [3.1.0] hex-6-ylmethyl]-2-hydroxy-N-methyl-2, 2-diphenylacetamide), a novel muscarinic receptor antagonist, was synthesized for the treatment of overactive bladder. Here we describe the in vitro and in vivo profiles of AE9C90CB for action in bladder over salivary gland and compare it with four agents already in clinical use (tolterodine, oxybutynin, solifenacin and darifenacin). Experimental approach: Radioligand binding assay and isolated tissue-based functional assay were used to evaluate affinity, potency, and receptor subtype selectivity of compounds. Inhibition of carbachol-induced increase in intravesicular pressure and salivary secretion were measured in anaesthetized rabbits to assess the functional selectivity. Key results: In vitro radioligand binding study using human recombinant muscarinic receptors showed that AE9C90CB had greater affinity for M3 muscarinic receptors with pKi of 9.90 ± 0.11 and was 20-fold more selective for M3 than for M2 muscarinic receptors. AE9C90CB exhibited an unsurmountable antagonism on rat bladder strips (pKB, 9.13 ± 0.12). In anaesthetized rabbits after intravenous administration, AE9C90CB dose dependently inhibited carbachol-induced increase in intravesicular pressure and salivary secretion, and exhibited functional selectivity for urinary bladder over salivary gland which was ninefold better than that of oxybutynin. Conclusions and implications: We have identified AE9C90CB, a compound exhibiting moderate selectivity for M3 over M2 receptors but greater selectivity for urinary bladder over salivary gland than oxybutynin, tolterodine, solifenacin and darifenacin. Therefore, AE9C90CB may be a promising compound for the treatment of overactive bladder with reduced potential to cause dry mouth than currently available antimuscarinic drugs." @default.
• W1511204218 created "2016-06-24" @default.
• W1511204218 creator A5007218289 @default.
• W1511204218 creator A5008803520 @default.
• W1511204218 creator A5035647204 @default.
• W1511204218 creator A5040209327 @default.
• W1511204218 creator A5046148679 @default.
• W1511204218 creator A5059548549 @default.
• W1511204218 creator A5060187875 @default.
• W1511204218 creator A5060693560 @default.
• W1511204218 creator A5067127837 @default.
• W1511204218 creator A5080880873 @default.
• W1511204218 creator A5085145621 @default.
• W1511204218 date "2010-03-19" @default.
• W1511204218 modified "2023-09-25" @default.
• W1511204218 title "AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder" @default.
• W1511204218 cites W1599348510 @default.
• W1511204218 cites W1938705645 @default.
• W1511204218 cites W1963818524 @default.
• W1511204218 cites W1968860914 @default.
• W1511204218 cites W1983621806 @default.
• W1511204218 cites W1983993832 @default.
• W1511204218 cites W1989309123 @default.
• W1511204218 cites W1991693093 @default.
• W1511204218 cites W1997875604 @default.
• W1511204218 cites W2001814576 @default.
• W1511204218 cites W2021199089 @default.
• W1511204218 cites W2022805127 @default.
• W1511204218 cites W2041658692 @default.
• W1511204218 cites W2043005695 @default.
• W1511204218 cites W2046564720 @default.
• W1511204218 cites W2050598861 @default.
• W1511204218 cites W2051857767 @default.
• W1511204218 cites W2057739880 @default.
• W1511204218 cites W2058955332 @default.
• W1511204218 cites W2060209468 @default.
• W1511204218 cites W2074631079 @default.
• W1511204218 cites W2085825893 @default.
• W1511204218 cites W2092473900 @default.
• W1511204218 cites W2094573426 @default.
• W1511204218 cites W2094970779 @default.
• W1511204218 cites W2105201781 @default.
• W1511204218 cites W2131173377 @default.
• W1511204218 cites W2136032492 @default.
• W1511204218 cites W2148524234 @default.
• W1511204218 cites W2419325913 @default.
• W1511204218 cites W2419515500 @default.
• W1511204218 doi "https://doi.org/10.1111/j.1476-5381.2010.00752.x" @default.
• W1511204218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2936021" @default.
• W1511204218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20590605" @default.
• W1511204218 hasPublicationYear "2010" @default.
• W1511204218 type Work @default.
• W1511204218 sameAs 1511204218 @default.
• W1511204218 citedByCount "10" @default.
• W1511204218 countsByYear W15112042182014 @default.
• W1511204218 countsByYear W15112042182017 @default.
• W1511204218 countsByYear W15112042182018 @default.
• W1511204218 countsByYear W15112042182019 @default.
• W1511204218 countsByYear W15112042182021 @default.
• W1511204218 countsByYear W15112042182022 @default.
• W1511204218 countsByYear W15112042182023 @default.
• W1511204218 crossrefType "journal-article" @default.
• W1511204218 hasAuthorship W1511204218A5007218289 @default.
• W1511204218 hasAuthorship W1511204218A5008803520 @default.
• W1511204218 hasAuthorship W1511204218A5035647204 @default.
• W1511204218 hasAuthorship W1511204218A5040209327 @default.
• W1511204218 hasAuthorship W1511204218A5046148679 @default.
• W1511204218 hasAuthorship W1511204218A5059548549 @default.
• W1511204218 hasAuthorship W1511204218A5060187875 @default.
• W1511204218 hasAuthorship W1511204218A5060693560 @default.
• W1511204218 hasAuthorship W1511204218A5067127837 @default.
• W1511204218 hasAuthorship W1511204218A5080880873 @default.
• W1511204218 hasAuthorship W1511204218A5085145621 @default.
• W1511204218 hasBestOaLocation W15112042181 @default.
• W1511204218 hasConcept C116289061 @default.
• W1511204218 hasConcept C126322002 @default.
• W1511204218 hasConcept C134018914 @default.
• W1511204218 hasConcept C142724271 @default.
• W1511204218 hasConcept C170493617 @default.
• W1511204218 hasConcept C185592680 @default.
• W1511204218 hasConcept C204787440 @default.
• W1511204218 hasConcept C2776885963 @default.
• W1511204218 hasConcept C2777844464 @default.
• W1511204218 hasConcept C2778941218 @default.
• W1511204218 hasConcept C2778988552 @default.
• W1511204218 hasConcept C2779502394 @default.
• W1511204218 hasConcept C2781020410 @default.
• W1511204218 hasConcept C33789571 @default.
• W1511204218 hasConcept C47488739 @default.
• W1511204218 hasConcept C55493867 @default.
• W1511204218 hasConcept C71924100 @default.
• W1511204218 hasConcept C98274493 @default.
• W1511204218 hasConceptScore W1511204218C116289061 @default.
• W1511204218 hasConceptScore W1511204218C126322002 @default.
• W1511204218 hasConceptScore W1511204218C134018914 @default.
• W1511204218 hasConceptScore W1511204218C142724271 @default.
• W1511204218 hasConceptScore W1511204218C170493617 @default.
• W1511204218 hasConceptScore W1511204218C185592680 @default.

• next